admin

Elizabeth is the interim Managing Director of TEDCO’s MVF.  She brings more than 25 years of academic, government, and private sector experience in product development, technology commercialization and venture management experience to the team.  Prior to joining TEDCO, she served as President of Transition Health Ventures, a consulting firm specializing in serving the needs of the innovation community and the healthcare and life science startup companies within it.  Elizabeth also spent more than 8 years in academic venturing roles JHU and UMB.  Additionally, Elizabeth previously served as Managing Director of the MVF (2004-2006) in addition to progressively senior roles with the Fund between 2000-2004.  She started her career in San Diego in venture-backed medtech startups in product development roles after completing her Masters in Bioengineering from UC San Diego, and BSE from Duke University and Biomedical and Electrical Engineering.

Some of the nation’s top healthcare-focused venture capital firms are banding together to form an advisory council with the technology security certification provider HITRUST  to create best practices for data security for startups developing digital health technologies.

In the heart of Montgomery County, Maryland’s premier biotech district there is a 42,000 SF facility with 17,000 SF vacant lab/office suite located at 9900 Medical Center Drive. The newly delivered and available lab space was designed to foster collaboration and learning with an open layout, a welcoming courtyard and an inside common area that is shared with other local tenants. 

Image: https://biobuzz.io

Maryland Technology Development Corp. has tapped an interim leader for the Maryland Venture Fund, which was the subject of a damaging state audit report and subsequent reform legislation earlier this year.

Elizabeth Good Mazhari has been named the interim managing director of TEDCO’s Maryland Venture Fund or MVF. The appointment comes as TEDCO is finalizing new governing regulations that it hopes will meet legislators’ expectations of how it should be distributing state funds to Maryland startups. New investments through the MVF have been halted since June, while TEDCO enacts legislative-directed reforms and works to fill executive positions left open by a slew of recent resignations. Former MVF Managing Director Andy Jones announced his departure from TEDCO in May.

Having an MRI scan can be an unpleasant experience. The procedure often involves a patient lying down inside a large tube for at least 30 minutes and being instructed to remain motionless as magnetic and radio waves create detailed pictures of their organs. Many find the machine’s loud, clanging noises unnerving and are left feeling panicky and claustrophobic.

Image: Johns Hopkins doctoral student Puyang Wang – https://hub.jhu.edu

Merger and acquisitions (M&A) activity within the healthcare industry heightened last year, according to recent research data and this could feed into gains for M&A and healthcare-focused ETFs for traders sensing an opportunity.

“The U.S. healthcare market saw a 14.4 percent increase in mergers and acquisitions from 2017-2018, fueled by soaring domestic venture capital investment – an all-time high of $130.9 billion invested in U.S.-based startups in 2018 alone,” a press release by Sage Growth Partners said. “Compounding the pace and complexity of deal flow are sweeping industry trends ranging from managing and measuring health outcomes to reducing the overall cost of care.”

A key part of president Donald Trump’s strategy to cut drug prices was to attack global “freeloading” for pharmaceuticals, targeting countries pushing back against pharma companies trying to charge higher US-level prices for their products.

But in trade negotiations with Canada and Mexico, it looks like that the Trump administration has not followed through on the strong rhetoric set out in his drug pricing strategy published last year.

According to press reports Trump’s negotiating team have agreed to scrap provisions on exclusivity of biologics, allowing each country to decide when the patent protection period expires on biologics.

Nearly 400 biotech leaders from across the Biohealth Capital Region (BHCR) gathered recently in Bethesda, Maryland at the Bio Innovation Conference, hosted by Maryland Life Sciences (MDLS), a division of the Maryland Tech Council. The event focused on advancements and opportunities for Maryland cell and gene therapy companies and why Maryland is becoming the number one location of choice for growing biotech companies. However, it was the afternoon keynote featuring JLABS @Washintgon, DC’s Michelle McMurry-Heath, MD, PhD, that caused a buzz in the crowd. 

Image: https://biobuzz-io.cdn.ampproject.org

Trump‘s choice to lead the Food and Drug Administration has ties to both Wall Street and drug makers

A conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry is President Donald Trump‘s pick to lead the Food and Drug Administration.

Dr Scott Gottlieb, 44, would be tasked with Trump‘s goal of cutting red tape at the FDA, which regulates everything from pharmaceuticals to seafood to electronic cigarettes. 

Rockville, MD: December 10, 2019. Robovet Corporation, a Rockville, Maryland startup focused on building novel veterinary diagnostic imaging systems, today announced it has begun raising funds through an equity crowdfunding campaign on the Wefunder platform (www.Wefunder.com/robovet). Robovet’s novel MRI systems for veterinary diagnostic imaging, robotic surgery and image guided therapy are expected to dramatically reduce the costs of advanced diagnostic imaging and veterinary cancer treatment. The company, headed by veterinary radiologist MC Seward DVM, MS, MBA, utilizes novel magnetic systems initially developed within the Weinberg Medical Physics incubator. According to Dr. Seward, “When I learned about Robovet’s MRI and image-guided treatment technology, it was easy to see the potential applications to the broader veterinary market in advanced diagnostic imaging and innovative therapies for equine and small animal veterinary patients”. “Dr. Seward’s academic work in MRI-guided therapy and his entrepreneurial experience make him the ideal CEO for the company,“ stated Irving Weinberg, MD PhD, co-founder. About Robovet Corporation